[EN] SUBSTITUTED PYRROLIDINES AND THEIR USE<br/>[FR] PYRROLIDINES SUBSTITUÉES ET LEUR UTILISATION
申请人:ABBVIE SARL
公开号:WO2019193062A1
公开(公告)日:2019-10-10
The invention discloses compounds of Formula (I) wherein R1, R2, R3, R3A, R4, and R5 are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
Process for Producing an Aromatic Unsaturated Compound
申请人:Wang Weiqi
公开号:US20080221337A1
公开(公告)日:2008-09-11
The present invention provides a process for producing an aromatic unsaturated compound of the formula (4)
wherein Ar represents an optionally substituted aromatic group or an optionally substituted heteroaromatic group, and Y represents an electron withdrawing group,
which comprises reacting
(a) a compound of the formula (1)
Ar—H (1)
wherein Ar has the same meaning as defined above with
(b) a compound of the formula (2)
wherein Y has the same meaning as defined above, and Z represents a lower alkoxy, or
a compound of the formula (3)
wherein Y and Z have the same meanings as defined above, in the presence of
(c) an acid or a compound which generates a mineral acid by its hydrolysis.
PROCESS FOR PRODUCING AN AROMATIC UNSATURATED COMPOUND
申请人:WANG Weiqi
公开号:US20090111999A1
公开(公告)日:2009-04-30
The present invention provides a process for producing an aromatic unsaturated compound of the formula (4)
wherein Ar represents an optionally substituted aromatic group or an optionally substituted heteroaromatic group, and Y represents an electron withdrawing group,
which comprises reacting
(a) a compound of the formula (1)
Ar—H (1)
wherein Ar has the same meaning as defined above
with
(b) a compound of the formula (2)
wherein Y has the same meaning as defined above, and Z represents a lower alkoxy, or
a compound of the formula (3)
wherein Y and Z have the same meanings as defined above,
in the presence of
(c) an acid or a compound which generates a mineral acid by its hydrolysis.
Amino-aryl-benzamide compounds and methods of use thereof
申请人:HEPANOVA, INC.
公开号:US11000491B2
公开(公告)日:2021-05-11
A method for the treatment and/or reduction of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) is disclosed. The method uses active amino-aryl-benzamide compounds and methods for the preparation thereof.